Tyra Biosciences, Inc. - Common Stock (NQ:TYRA)

21.52 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tyra Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 25, 2024

Via Benzinga

Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday? ↗

October 25, 2024

Tyra Biosciences shares TYRA-300 Phase 1/2 data in metastatic urothelial cancer with 100% disease control at ≥90 mg doses and favorable safety.

Via Benzinga

BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug ↗

October 18, 2024

Tyra Biosciences receives an upgrade from BofA, raising the price target to $31. The upgrade follows promising preclinical data for TYRA-300 and increased sales projections for metastatic urothelial...

Via Benzinga

This Datadog Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗

October 18, 2024

Via Benzinga

TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm

August 20, 2024

From The Schall Law Firm

Via Business Wire

Analyst Ratings for Tyra Biosciences ↗

August 11, 2023

Via Benzinga

Where Tyra Biosciences Stands With Analysts ↗

May 08, 2023

Via Benzinga

TYRA Stock Earnings: Tyra Biosciences Beats EPS for Q2 2024 ↗

August 07, 2024

TYRA stock results show that Tyra Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

TYRA Stock Earnings: Tyra Biosciences Beats EPS for Q1 2024 ↗

May 09, 2024

TYRA stock results show that Tyra Biosciences beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

TYRA Stock Earnings: Tyra Biosciences Misses EPS for Q4 2023 ↗

March 19, 2024

TYRA stock results show that Tyra Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

S&P 500 Gains Over 1%; Amazon Earnings Top Expectations ↗

February 02, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded up 0.49% to 38,705.29 while the NASDAQ rose 1.81% to 15,639.81. The S&P 500...

Via Benzinga

Topics Stocks

The Latest Analyst Ratings for Tyra Biosciences ↗

March 23, 2023

Via Benzinga

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 02, 2024

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 02, 2024

Via Benzinga

Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings ↗

February 02, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 500...

Via Benzinga

Topics Stocks

Clorox Posts Upbeat Earnings, Joins Cigna, Deckers Outdoor And Other Big Stocks Moving Higher On Friday ↗

February 02, 2024

U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday.

Via Benzinga

Topics Stocks

Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday ↗

November 20, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday ↗

May 23, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 10, 2023

Via Benzinga

Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗

March 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

US Stocks Higher, NASDAQ Adds Over 230 Points ↗

February 02, 2023

US stocks traded higher this morning, with the NASDAQ gaining more than 230 points on Thursday. Following the market opening Thursday, the Dow traded up 0.02% to 34,092.96, while the NASDAQ rose 2.00%...

Via Benzinga

Dow Dips 300 Points; Snap Shares Plunge ↗

February 01, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday ↗

September 30, 2022

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.